Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities, calculated as total liabilities divided by total asset. Zhejiang Zhenyuan Share Co's Total Liabilities for the quarter that ended in Mar. 2026 was ¥983 Mil. Zhejiang Zhenyuan Share Co's Total Assets for the quarter that ended in Mar. 2026 was ¥2,928 Mil.
Therefore, Zhejiang Zhenyuan Share Co's Liabilities-to-Assets Ratio for the quarter that ended in Mar. 2026 was 0.34.
Zhejiang Zhenyuan Share Co (SZSE:000705) Liabilities-to-Assets Explanation
Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.
Zhejiang Zhenyuan Share Co Liabilities-to-Assets Related Terms
Zhejiang Zhenyuan Share Co Liabilities-to-Assets Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhejiang Zhenyuan Share Co Liabilities-to-Assets Chart
SZSE:000705 vs LLY, JNJ, ABBV: Liabilities-to-Assets Comparison
For the Drug Manufacturers - General subindustry, Zhejiang Zhenyuan Share Co's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhejiang Zhenyuan Share Co Liabilities-to-Assets vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Zhejiang Zhenyuan Share Co's Liabilities-to-Assets distribution charts can be found below:
* The bar in red indicates where Zhejiang Zhenyuan Share Co's Liabilities-to-Assets falls into.
Zhejiang Zhenyuan Share Co Liabilities-to-Assets Calculation
Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.
Zhejiang Zhenyuan Share Co's Liabilities-to-Assets Ratio for the fiscal year that ended in Dec. 2025 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhejiang Zhenyuan Share Co (SZSE:000705) has a Liabilities-to-Assets of 0.34 as of Mar. 2026. Liabilities-to-Assets equals total liabilities divided by total assets. It measures financial leverage. View historical data on Zhejiang Zhenyuan Share Co and its competitors.
Is Zhejiang Zhenyuan Share Co's Liabilities-to-Assets too high?
Zhejiang Zhenyuan Share Co's current Liabilities-to-Assets is 0.34. Overall, Zhejiang Zhenyuan Share Co has a GF Score™ of 48/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Zhenyuan Share Co's Liabilities-to-Assets compare to LLY and JNJ?
Zhejiang Zhenyuan Share Co's Liabilities-to-Assets of 0.34 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Liabilities-to-Assets for a Drug Manufacturers company?
A good Liabilities-to-Assets depends on the Drug Manufacturers industry context. However, Liabilities-to-Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Liabilities-to-Assets mean?
A high Liabilities-to-Assets can signal that a stock is expensive relative to its fundamentals. Liabilities-to-Assets equals total liabilities divided by total assets. It measures financial leverage. View historical data on Zhejiang Zhenyuan Share Co and its competitors. Zhejiang Zhenyuan Share Co's current Liabilities-to-Assets is 0.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Zhenyuan Share Co stock overvalued right now?
Based on GuruFocus' analysis, Zhejiang Zhenyuan Share Co (SZSE:000705) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥4.22, compared to a current price of ¥6.22 — trading 47.4% above its estimated fair value. The current Liabilities-to-Assets is 0.34. Zhejiang Zhenyuan Share Co's overall GF Score™ is 48/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Liabilities-to-Assets calculated?
Liabilities-to-Assets is calculated from a company's financial statements. For Zhejiang Zhenyuan Share Co (SZSE:000705), the current Liabilities-to-Assets is 0.34 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zhejiang Zhenyuan Share Co (SZSE:000705) Overvalued in 2026?
Based on GuruFocus' analysis, Zhejiang Zhenyuan Share Co stock appears to be overvalued.
The current stock price of ¥6.22 is trading 47.4% above its estimated GF Value™ of ¥4.22.
GuruFocus considers Zhejiang Zhenyuan Share Co to be Significantly Overvalued.
Key valuation signals for SZSE:000705:
Liabilities-to-Assets: 0.34
GF Value™: ¥4.22 vs. price of ¥6.22 (47.4% above fair value)
No single metric tells the full story. See the SZSE:000705 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zhejiang Zhenyuan Share Co Ltd is a China based pharmaceutical company. It is engaged in the engaged in the production and operation of proprietary Chinese medicines, Chinese herbal medicines, Chinese herbal medicines, chemical preparations, chemical raw materials, biochemical drugs, narcotic drugs, psychotropic drugs, medical devices, chemical reagent and others. Further, the firm's business scope covers the pharmaceutical industry, pharmaceutical business, pharmaceutical logistics and health service industry. It holds presence in both Chinese and international market.
48GF Score
Get the complete analysis for SZSE:000705
Liabilities-to-Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SZSE:000705 has been successfully added to your 
